Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: GKRichard / Re: My 2 cents on the R/S discussion

"Not necessarily, as at $6, a much different pool of potential investors could buy."

If there's no consistent revenue, those different pool of investors won't buy one share and investors will short the h%ll out of it. The SP will go from $6 back to .60 in a few weeks. People think there's a lot of shorting happening on the BB? The shorting on the BB is nothing compared to the shorting on the NASDAQ. Take a look at what happened with Pluristem (PSTI). They did a reverse split to get on the NASDAQ and are now trading in the .40s. Not pretty for shareholders. I don't know what their management was thinking - they certainly weren't thinking about their shareholders that's for sure.

1
Jan 08, 2009 01:25PM
1
Jan 09, 2009 05:57AM
Share
New Message
Please login to post a reply